跳至主要内容
临床试验/TCTR20200222006
TCTR20200222006尚未招募3 期

The Percentage of Complete Burn Wound Closure Assessment by Indocyanine Green Angiography: A Prospective Multicenter Study

one0 个研究点目标入组 30 人开始时间: 2020年2月22日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
one
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Inclusion criteria are that patients must be admitted to the hospital with indeterminate burn wounds on any part of the body. They are over 18 years old and are hemodynamically stable (mean arterial pressure ≥ 65 mmHg, urine output of 0.5-1 mL/kg/h, and adequate conscious to understand the study protocol), so they could decide whether to participate to this study or not. Written or fingerprint informed consent is obtained from all participants.

排除标准

  • Exclusion criteria are an allergy to ICG and iodides, pregnancy, bleeding tendency, and psychiatric disorder. Patients are also excluded if they have comorbidities that can alter the wound outcomes, including diabetes mellitus, malnutrition, current active infection, immunocompromised host, obesity, old age (over 65 years old), and anti-inflammatory drug use. Indeterminate wound areas that contained scars, moles, or tattoos are excluded. Participants who are not willing to travel to the 1-month wound assessment are excluded.

研究者

发起方
one

相似试验

已完成
不适用
An Open Single-centre Investigation Evaluating Efficacy in Second Degree Partial Thickness Burns Using a Silicone Contact Layer Containing Silver.Wound Healing
NCT01734317Molnlycke Health Care AB10
进行中(未招募)
不适用
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CR-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trial
EUCTR2005-005139-84-ATPIERRE FABRE MEDICAMENT200
进行中(未招募)
不适用
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CT-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialocally advanced non small cell lung cancer
EUCTR2005-005139-84-CZPIERRE FABRE MEDICAMENT200
进行中(未招募)
1 期
Evaluation of the rate of pathological complete response rate (pCR) for neoadjuvant chemoradiotherapy (CT-RT) and for chemotherapy (CT) alone in locally advanced non small cell lung cancer (LA-NSCLC): a randomised phase II trialocally advanced non small cell lung cancerMedDRA version: 8.1Level: LLTClassification code 10025044Term: Lung cancer
EUCTR2005-005139-84-FIPIERRE FABRE MEDICAMENT200
未知
不适用
Evaluation of effectiveness of wound closure after gastric/ rectal endoscopic submucosal dissection by using endoscopic suturing device.post-ESD ulcer
JPRN-UMIN000022370The Jikei university school of medicine Department of endoscopy10